Skip to main content
Atrás
Watch Compare

CalciMedica, Inc.

Calidad de datos: 83%
CALC
Nasdaq Manufacturing Chemicals
$0.66
▲ $0.04 (6.42%)
Cap. Mercado: 10.44 M
Precio
$0.66
Cap. Mercado
10.44 M
Rango del Día
$0.61 — $0.70
Rango de 52 Semanas
$0.46 — $7.20
Volumen
434,085
Apertura $0.62
Promedio 50D / 200D
$0.94
29.20% below
Promedio 50D / 200D
$2.86
76.81% below

Quick Summary

Puntos Clave

Negative free cash flow of -21.21 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-1013.26%
Below sector avg (-51.02%)
ROIC-136.13%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio4.04
Interest Coverage-16.26

Valoración

PE (TTM)
-0.35
Above sector avg (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -0.4 -2.0
P/B — 5.1
ROE % -1013.3 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -29.56 M
ROE -1013.26% ROA -173.93%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -21.21 M
ROIC -136.13% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.04
Interest Coverage -16.26 Asset Turnover N/A
Working Capital 11.17 M Tangible Book Value -268,000
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.35 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -203.22%
Market Cap 10.44 M Enterprise Value 4.97 M
Per Share
EPS (Diluted TTM) -1.97 Revenue / Share N/A
FCF / Share -1.35 OCF / Share -1.35
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 71.73%
SBC-Adj. FCF -24.34 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -29.56 M -13.70 M -34.36 M -35.61 M -35.82 M
EPS (Diluted) -1.97 -1.22 -7.66 -1.66 —
Gross Profit — — — — —
Operating Income -23.12 M -24.20 M -38.08 M -36.18 M -35.95 M
EBITDA — — — — —
R&D Expenses 15.23 M 14.48 M 15.86 M 14.11 M 18.90 M
SG&A Expenses — — — — —
D&A — — 58,000.0 — —
Interest Expense 1.42 M — — — —
Income Tax 0.0 0.0 1,000.0 — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 13.59 M 19.79 M 12.19 M 39.67 M 69.09 M
Total Liabilities 20.23 M 5.38 M 4.03 M 3.70 M 4.07 M
Shareholders' Equity -6.64 M 14.41 M 8.16 M 35.97 M 65.02 M
Total Debt — — — — —
Cash & Equivalents 11.52 M 7.94 M 5.53 M 17.30 M 13.36 M
Current Assets 13.53 M 19.67 M 11.61 M 39.67 M 67.08 M
Current Liabilities 3.78 M 3.68 M 4.03 M 3.70 M 4.06 M